DocDollars

Ceribell, Inc.

CA · United States · Reporting entity ID 100000196786

Total reported 2019–2025
$8.62M
#541 of 2,960 reporting companies — 0% of all reported industry payments
$6.77M in general payments across 3,895 records, plus $1.72M in research funding across 39 records.

How it breaks down

General payments $6,765,970
Research funding $1,719,244
Ownership & investment $133,789

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ceribell, Inc. reported $8.62M to US doctors and teaching hospitals from 2019 to 2025, ranking #541 of 2,960 reporting companies. 20% of that was research funding and 80% general payments such as consulting, speaking, food and travel. 3,895 general payment records and 39 research records were filed.

Common questions about Ceribell, Inc.

How much has Ceribell, Inc. paid US doctors?

Ceribell, Inc. reported $8,619,003 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,765,970 in general payments, $1,719,244 in research funding and $133,789 in ownership and investment interests.

How does Ceribell, Inc. rank among drug and device companies?

It ranks #541 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ceribell, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.